Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2028

Conditions
Rhabdomyosarcoma
Interventions
BIOLOGICAL

mRNA Tumor Vaccine Therapy

personalized mRNA vaccines

All Listed Sponsors
lead

Xinxin Zhang

OTHER